Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer (ARMOR2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01709734
Recruitment Status : Completed
First Posted : October 18, 2012
Last Update Posted : August 3, 2018
Information provided by (Responsible Party):
Novus Therapeutics, Inc

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2016
Actual Study Completion Date : September 2016